Anti-HTATIP2 monoclonal antibody
Pre-made anti-HTATIP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to HTATIP2/HTATIP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0158-Ab-1/ GM-Tg-hg-IP0158-Ab-2 | Anti-Human HTATIP2 monoclonal antibody | Human |
GM-Tg-rg-IP0158-Ab-1/ GM-Tg-rg-IP0158-Ab-2 | Anti-Rat HTATIP2 monoclonal antibody | Rat |
GM-Tg-mg-IP0158-Ab-1/ GM-Tg-mg-IP0158-Ab-2 | Anti-Mouse HTATIP2 monoclonal antibody | Mouse |
GM-Tg-cynog-IP0158-Ab-1/ GM-Tg-cynog-IP0158-Ab-2 | Anti-Cynomolgus/ Rhesus macaque HTATIP2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0158-Ab-1/ GM-Tg-felg-IP0158-Ab-2 | Anti-Feline HTATIP2 monoclonal antibody | Feline |
GM-Tg-cang-IP0158-Ab-1/ GM-Tg-cang-IP0158-Ab-2 | Anti-Canine HTATIP2 monoclonal antibody | Canine |
GM-Tg-bovg-IP0158-Ab-1/ GM-Tg-bovg-IP0158-Ab-2 | Anti-Bovine HTATIP2 monoclonal antibody | Bovine |
GM-Tg-equg-IP0158-Ab-1/ GM-Tg-equg-IP0158-Ab-2 | Anti-Equine HTATIP2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0158-Ab-1/ GM-Tg-hg-IP0158-Ab-2; GM-Tg-rg-IP0158-Ab-1/ GM-Tg-rg-IP0158-Ab-2; GM-Tg-mg-IP0158-Ab-1/ GM-Tg-mg-IP0158-Ab-2; GM-Tg-cynog-IP0158-Ab-1/ GM-Tg-cynog-IP0158-Ab-2; GM-Tg-felg-IP0158-Ab-1/ GM-Tg-felg-IP0158-Ab-2; GM-Tg-cang-IP0158-Ab-1/ GM-Tg-cang-IP0158-Ab-2; GM-Tg-bovg-IP0158-Ab-1/ GM-Tg-bovg-IP0158-Ab-2; GM-Tg-equg-IP0158-Ab-1/ GM-Tg-equg-IP0158-Ab-2 |
Products Name | Anti-HTATIP2 monoclonal antibody |
Format | mab |
Target Name | HTATIP2 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-HTATIP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0158-Ag-1 | Recombinant multi-species HTAI2/ HTATIP2/ CC3 protein |
ORF Viral Vector | vGMLP004848 | human HTATIP2 Lentivirus particle |
ORF Viral Vector | vGMLV000409 | human HTATIP2 Lentivirus particle |
ORF Viral Vector | pGMLP004848 | human HTATIP2 Lentivirus plasmid |
ORF Viral Vector | pGMLV000409 | human HTATIP2 Lentivirus plasmid |
ORF Viral Vector | pGMLPm005120 | mouse Htatip2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm005120 | mouse Htatip2 Lentivirus particle |
Target information
Target ID | GM-IP0158 |
Target Name | HTATIP2 |
Gene ID | 10553,53415,292935,701908,476886,101084478,539276,100057340 |
Gene Symbol and Synonyms | CC3,HTATIP2,SDR44U1,TIP30 |
Uniprot Accession | Q9BUP3 |
Uniprot Entry Name | HTAI2_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000109854 |
Target Classification | N/A |
The target: HTATIP2, gene name: HTATIP2, also named as CC3, SDR44U1, TIP30. Enables protein serine/threonine kinase activity. Involved in import into nucleus and regulation of angiogenesis. Acts upstream of or within positive regulation of programmed cell death; positive regulation of transcription by RNA polymerase II; and protein autophosphorylation. Located in cytosol and nuclear envelope. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.